Turnstone Biologics Corp Sustainability Reports
Turnstone Biologics Corp. is a biotechnology company focused on developing new medicines to treat and cure patients with solid tumors. The company utilizes a differentiated approach to tumor-infiltrating lymphocyte (TIL) therapy to target diverse cancer indications.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
1 reports from 2023 to 2023
Company Profile
Turnstone Biologics Corp. is a biotechnology company focused on developing new medicines to treat and cure patients with solid tumors. The company utilizes a differentiated approach to tumor-infiltrating lymphocyte (TIL) therapy to target diverse cancer indications.
Reports
1 total
Limited sustainability disclosure available
This company only publishes Annual Reports without dedicated sustainability sections.
Years